| # | % | |||||
|---|---|---|---|---|---|---|
| 151 | DEPOMED INC | 20,255 | 382,000 | 0.16% | ||
| 152 | IRIDIUM COMMUNICATIONS INC | 61,539 | 378,000 | 0.16% | ||
| 153 | TRONOX LTD SHS CL A | 83,753 | 366,000 | 0.15% | ||
| 154 | CAESARS ENTERTAINMENT | 60,933 | 359,000 | 0.15% | ||
| 155 | AMAG PHARMACEUTICALS INC | 8,894 | 353,000 | 0.14% | ||
| 156 | PDL BIOPHARMA INC | 64,473 | 324,000 | 0.13% | ||
| 157 | OASIS PETE INC NEW | 36,607 | 318,000 | 0.13% | ||
| 158 | VIAD CORP | 9,855 | 286,000 | 0.12% | ||
| 159 | MOVADO GROUP INC | 9,881 | 255,000 | 0.10% | ||
| 160 | INFINITY PHARMACEUTICALS INC | 23,546 | 199,000 | 0.08% | ||
| 161 | BROCADE COMMUNICATIONS SYS I | 16,730 | 174,000 | 0.07% | ||
| 162 | CLIFFS NAT RES INC | 17,681 | 43,000 | 0.02% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-15-001898, filed 2015.11.09).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
